UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017342
Receipt number R000020122
Scientific Title Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers
Date of disclosure of the study information 2015/05/01
Last modified on 2018/11/01 10:36:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Acronym

Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Scientific Title

Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Scientific Title:Acronym

Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers

Region

Japan


Condition

Condition

Healthy Volunteers

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The efficiency of Lubiprostone in intestinal permeability

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Permeability of the small intestine using the lactulose/mannitol test

Key secondary outcomes

Endotoxin activity in blood, changes in the intestinal flora


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

24mcg of Lubiprostone once daily after lunch for 14 days or 28 days

Interventions/Control_2

No treatment for 14 days or 28 days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

1)Men at age >=20 years but <60 years when the consent was obtained
2)Persons who were determined to be healthy adults by the investigator/sub-investigator (hereinafter referred to as investigator, etc.) during medical interview at screening
3)Persons from whom the written consent was obtained and who can abide by the compliance rules while participating in this study, receive medical examination and tests prescribed in this protocol, and report symptoms, etc.

Key exclusion criteria

1)Persons who have received NSAIDs within 3 months before obtaining the consent (excluding topical administration of NSAIDs)
2)Persons with history of food or drug allergy (diclofenac sodium, lubiprostone, etc.) or who are suspected of such allergy
3)Persons with current or history of serious cardiovascular/vascular, hematological, respiratory, liver, kidney, gastrointestinal, or neuropsychiatric disease
4)Persons who are taking proton pump inhibitors (PPIs), antibiotics, or intestinal drugs (excluding topical administration of antibiotics)
5)Persons who have participated in other clinical studies and received the study drug, etc. within 1 month prior to the start of this study (calculated from the administration date of the study drug)
6)Persons who were judged by the investigator, etc. to be inappropriate as a subject for this study

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroki Endo

Organization

Yokohama City University

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan

TEL

045-787-2800ext.6600

Email

endo1978@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroki Endo

Organization

Yokohama City University

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan

TEL

045-787-2800ext.6600

Homepage URL


Email

endo1978@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

Abbott Japan Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属病院


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0175626

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 26 Day

Date of IRB


Anticipated trial start date

2015 Year 05 Month 11 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 03 Month 31 Day

Date analysis concluded

2016 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 04 Month 30 Day

Last modified on

2018 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020122


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name